Title:
疼痛処置に使用可能なアミノホスフィン酸誘導体
Document Type and Number:
Japanese Patent JP5607045
Kind Code:
B2
Abstract:
[3-(Aminomethyl-hydroxy-phosphinoyl)-propionylamino]-acetic acid or its ester compounds (I) and their salts are new. [3-(Aminomethyl-hydroxy-phosphinoyl)-propionylamino]-acetic acid or its ester compounds of formula (R 1-NH-CH(R 2)-P(=O)(OR 3)-CH 2-C(R 4)(R 5)-CONH-CH(R 6)-COOR 7) (I) and their salts are new. R 1 : -C(=O)-O-C(R 8)(R 9)-OC(=O)-R 1 0; either R 8, R 9 : H or T; or CR 8R 9 : saturated 5 or 6 membered hydrocarbon ring; R 1 0 : T; T : alkyl, aryl, arylalkyl, cycloalkyl, cycloheteroalkyl, heteroalkyl, heteroalkyl, heteroaryl or heteroarylalkyl; R 2 : optionally saturated 1-6C hydrocarbon (optionally substituted by OR 1 1, SR 1 1, SOR 1 1, amino, or phenyl (optionally substituted by halo, preferably F)), heteroaryl, aryl (preferably phenyl optionally substituted by F), or methylene group substituted by a 5 or 6 membered heterocycle optionally saturated or aromatic, containing heteroatoms of S or N, optionally oxidized form of N-oxide or S-oxide; R 3 : H, or group of formula (C(R 1 3)(R 1 2)-OC(=O)-R 1 4); R 1 1 : H, benzyl or optionally saturated 1-4C hydrocarbon; either R 1 2, R 1 3 : H or T; or CR 1 2R 1 3 : 5 or 6 membered hydrocarbon ring; R 1 4 : T; either R 4 : benzyl or phenyl (optionally substituted by 1-5 halo (preferably Br or F), OR 1 5, SR 1 5, amino, CF 3, phenyl or 5 or 6 membered heteroaromatic ring), 5 or 6 membered heteroaromatic ring (comprising 1 or 2 heteroatoms of O, N or S and nitrogen can be oxidized form of N-oxide), or methylene group substituted by a 5 or 6 membered heterocycle optionally saturated or aromatic, containing one or more heteroatoms of S or N, optionally oxidized form of N-oxide or S-oxide; and R 5 : H; or CR 4R 5 : 5 or 6 membered hydrocarbon ring, or piperidine ring, where nitrogen is present in position 4, (optionally substituted by phenyl or benzyl (both optionally substituted by halo, 1-4C alkyl or 1-4C alkoxy), or aromatic heterocycle such as pyridine or pyrimidine (optionally substituted by 1-4C alkyl or 1-4C alkoxy), SO 2-phenyl, CF 3, 1-4C alkyl or 1-4C acyl); R 1 5, R 1 6 : H, benzyl or optionally saturated 1-4C hydrocarbon; R 6 : optionally saturated, 1-6C hydrocarbon (optionally substituted by OR 1 6, SR 1 6, SOR 1 6, COO-benzyl or COOH, SO 3H, or amino), phenyl (optionally substituted by halo such as Br or F, CF 3, OR 1 7, or benzyl), or benzyl (optionally substituted by halo such as Br or F, CF 3, OR 1 7, or phenyl); R 7> : H, benzyl, 2-4C alkyl, -CHR 1 8-COOR 1 9, -CHR 1 8-OCOR 1 9 or -CHR 1 8-OC(=O)OR 1 9; and R 1 8, R 1 9 : T. An independent claim is included for a composition comprising (I) and at least one vehicle. ACTIVITY : Analgesic. MECHANISM OF ACTION : None given.
Inventors:
Bernard, a lock
The Elbe, ポラ
Moray Claude, フルニエ‐ Zarsky
The Elbe, ポラ
Moray Claude, フルニエ‐ Zarsky
Application Number:
JP2011519156A
Publication Date:
October 15, 2014
Filing Date:
July 22, 2009
Export Citation:
Assignee:
ファルマリーズ PHARMALEADS
International Classes:
C07F9/32; A61K31/195; A61K31/662; A61K31/67; A61K31/675; A61P25/04; A61P29/00; A61P43/00
Attorney, Agent or Firm:
Katsunuma Hirohito
Yukitaka Nakamura
Nobutaka Yokota
Takehiro Ito
Yukitaka Nakamura
Nobutaka Yokota
Takehiro Ito